Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech to Use GE Healthcare s Labeling Technology in Microarray Kits

NEW YORK, Feb. 22 (GenomeWeb News) - Kreatech Biotechnology said yesterday that it has signed an agreement allowing it to use GE Healthcare's Universal Linkage System and fluorescent dye technology in DNA microarray-labeling kits.

 

Under the terms of the agreement, Kreatech gains global rights for the use of Cy3 and Cy5 dyes with the Universal Linkage System in fluorescent applications within the life sciences market, Kreatech said. Kreatech will use the technology to develop and manufacture microarray-labeling kits for amplified RNA labeling and genomic DNA labeling, it said.

 

Kreatech said the technology enables direct DNA labeling, negating the need for modified nucleotides.

 

Financial terms of the deal were not disclosed.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.